dpp 4 glp 1 DPP4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner GLP-1 Series Part 1: Utilization

Repurposing GLP-1 receptor agonists and novel dual/triple GLP-1, GIP, and glucagon agonists represent promising therapeutic strategies that have shown to be effective in targeting inflammation, tau phosphorylation, synaptic dysfunction, insulin resistance, and oxidative stress

With more melanin in our skin, the tone becomes noticeably darker and better protected from UV rays

Importantly, liraglutide has been found to modulate cytokine production in i NKT cells without impairing their cytotoxic function [77]

One common question that people have is, why are clinical trial healthy volunteers often a requirement during the early stages of the study

People commencing L-carnitine supplementation should commit to at least six months of use and evaluate effectiveness after this time